NDLR_conference
@ndlrconference.bsky.social
The official account for New Directions in Leukaemia Research Meeting. Adelaide, 2-4 March 2026.
Join the conversation with #NDLR2026.
For details visit: eventstudio.eventsair.com/ndlr-2026/
Join the conversation with #NDLR2026.
For details visit: eventstudio.eventsair.com/ndlr-2026/
🚀 #NDLR2026 is proud to announce its full scientific program! Join us for an unmissable gathering of global leaders sharing the latest breakthroughs in blood cancer research!
#BloodCancerResearch #MPN #Myeloma #ALL #AML #Lymphoma #MDS #PediatricLeukemia #SpatialProfiling #CML
#BloodCancerResearch #MPN #Myeloma #ALL #AML #Lymphoma #MDS #PediatricLeukemia #SpatialProfiling #CML
November 24, 2025 at 11:16 PM
🚀 #NDLR2026 is proud to announce its full scientific program! Join us for an unmissable gathering of global leaders sharing the latest breakthroughs in blood cancer research!
#BloodCancerResearch #MPN #Myeloma #ALL #AML #Lymphoma #MDS #PediatricLeukemia #SpatialProfiling #CML
#BloodCancerResearch #MPN #Myeloma #ALL #AML #Lymphoma #MDS #PediatricLeukemia #SpatialProfiling #CML
We’re thrilled to welcome #NDLR2026 speaker Anna Steiner, an MPN patient and passionate advocate for #MPN and #BloodCancer research, support, and prevention.
Anna's focus is on improving regional equity in diagnosis, treatment, and access to clinical trials.
Anna's focus is on improving regional equity in diagnosis, treatment, and access to clinical trials.
October 8, 2025 at 2:51 AM
We’re thrilled to welcome #NDLR2026 speaker Anna Steiner, an MPN patient and passionate advocate for #MPN and #BloodCancer research, support, and prevention.
Anna's focus is on improving regional equity in diagnosis, treatment, and access to clinical trials.
Anna's focus is on improving regional equity in diagnosis, treatment, and access to clinical trials.
We are thrilled to announce #NDLR2026 speaker Dr Cavan Bennett postdoctoral researcher @wehi-research.bsky.social. Cavan's research focuses on #haematology particular the effects of iron in #MyeloproliferativeNeoplasms. #BloodCancer #CancerResearch
September 22, 2025 at 11:24 PM
We are thrilled to announce #NDLR2026 speaker Dr Cavan Bennett postdoctoral researcher @wehi-research.bsky.social. Cavan's research focuses on #haematology particular the effects of iron in #MyeloproliferativeNeoplasms. #BloodCancer #CancerResearch
We are excited to announce #NDLR2026 speaker Chelsea Mayho from the Children's Cancer Institute. Chelsea is working on developing #Bioinformatics pipelines for the #ZeroChildhoodCancer Program #ClinicalTrials, including the development of a #DrugDiscovery pipeline. #Leukemia
September 21, 2025 at 10:17 PM
We are excited to announce #NDLR2026 speaker Chelsea Mayho from the Children's Cancer Institute. Chelsea is working on developing #Bioinformatics pipelines for the #ZeroChildhoodCancer Program #ClinicalTrials, including the development of a #DrugDiscovery pipeline. #Leukemia
We are excited to announce #NDLR2026 speaker Dr Raymond Yip from @wehi-research.bsky.social. Raymond’s current #CancerResearch focus is on the implementation of novel spatial #Omics to understand the bone microenvironment in #MultipleMyeloma.
September 18, 2025 at 9:50 PM
We are excited to announce #NDLR2026 speaker Dr Raymond Yip from @wehi-research.bsky.social. Raymond’s current #CancerResearch focus is on the implementation of novel spatial #Omics to understand the bone microenvironment in #MultipleMyeloma.
We are thrilled to announce #NDLR2026 speaker Dr Julie Thoms, from UNSW . Julie's research interests lie in understanding #GeneRegulation in #Leukemia driving stem cells to develop #TargetedTherapies.
#BloodCancer #CancerResearch #MyelodysplasticSyndromes #AcuteMyeloidLeukemia
#BloodCancer #CancerResearch #MyelodysplasticSyndromes #AcuteMyeloidLeukemia
September 17, 2025 at 10:23 PM
We are thrilled to announce #NDLR2026 speaker Dr Julie Thoms, from UNSW . Julie's research interests lie in understanding #GeneRegulation in #Leukemia driving stem cells to develop #TargetedTherapies.
#BloodCancer #CancerResearch #MyelodysplasticSyndromes #AcuteMyeloidLeukemia
#BloodCancer #CancerResearch #MyelodysplasticSyndromes #AcuteMyeloidLeukemia
We are excited to announce #NDLR2026 speaker Prof Hamish Scott, from SA Pathology. Hamish's #CancerResearch is on identifying #BloodCancer #Genetics for the use in #PersonalizedMedicine.
September 17, 2025 at 12:29 AM
We are excited to announce #NDLR2026 speaker Prof Hamish Scott, from SA Pathology. Hamish's #CancerResearch is on identifying #BloodCancer #Genetics for the use in #PersonalizedMedicine.
🚨 Call for Abstracts Now Open #NDLR2026 🚨
Only 1 week left to submit your abstracts!
🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
#BloodCancer
#CancerResearch
#ChildhoodCancer
Only 1 week left to submit your abstracts!
🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
#BloodCancer
#CancerResearch
#ChildhoodCancer
September 16, 2025 at 2:21 AM
🚨 Call for Abstracts Now Open #NDLR2026 🚨
Only 1 week left to submit your abstracts!
🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
#BloodCancer
#CancerResearch
#ChildhoodCancer
Only 1 week left to submit your abstracts!
🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
#BloodCancer
#CancerResearch
#ChildhoodCancer
We are excited to announce #NDLR2026 speaker, Assoc Prof @LevKats from @PeterMacCC. Lev's research includes #Epigenetic regulation, #Metabolism and #TargetedTherapies. His lab uses molecular and functional #Genomics to develop new treatment strategies for aggressive #BloodCancers
September 15, 2025 at 10:30 PM
We are excited to announce #NDLR2026 speaker, Assoc Prof @LevKats from @PeterMacCC. Lev's research includes #Epigenetic regulation, #Metabolism and #TargetedTherapies. His lab uses molecular and functional #Genomics to develop new treatment strategies for aggressive #BloodCancers
We are excited to announce our new #NDLR2026 Meet-the-Editor session, with Editors-in-Chief, Prof Andrew Roberts, @bloodjournals.hematology.org and Prof @jancools.bsky.social, @hemasphere-journal.bsky.social who will share their invaluable insights on #publishing in high-impact #hematology journals.
September 14, 2025 at 10:37 PM
We are excited to announce our new #NDLR2026 Meet-the-Editor session, with Editors-in-Chief, Prof Andrew Roberts, @bloodjournals.hematology.org and Prof @jancools.bsky.social, @hemasphere-journal.bsky.social who will share their invaluable insights on #publishing in high-impact #hematology journals.
We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.
September 12, 2025 at 12:04 AM
We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.
We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia.
September 10, 2025 at 10:38 PM
We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia.
We are excited to introduce #NDLR2026 speaker Dr Jennifer Devlin, one of from @petermaccc.bsky.social. Jennifer’s research focuses on dissecting the molecular mechanisms that control #GeneExpression to identify transcriptional vulnerabilities that may be exploited for #CancerTreatment.
September 9, 2025 at 9:40 PM
We are excited to introduce #NDLR2026 speaker Dr Jennifer Devlin, one of from @petermaccc.bsky.social. Jennifer’s research focuses on dissecting the molecular mechanisms that control #GeneExpression to identify transcriptional vulnerabilities that may be exploited for #CancerTreatment.
We are honoured to welcome clinician-scientist Prof Steven Lane from @qimrb.bsky.social as a speaker to #NDLR2026. Steven’s research concentrates on understanding how #leukemia stem cells in #AcuteMyeloidLeukemia and #MyeloproliferativeNeoplasm can regenerate leukemia.
September 8, 2025 at 10:07 PM
We are honoured to welcome clinician-scientist Prof Steven Lane from @qimrb.bsky.social as a speaker to #NDLR2026. Steven’s research concentrates on understanding how #leukemia stem cells in #AcuteMyeloidLeukemia and #MyeloproliferativeNeoplasm can regenerate leukemia.
We are thrilled to announce that Associate Professor @juliamaxson.bsky.social from @ohsuknight.bsky.social, USA, will be joining us at #NDLR2026. Julia's research focuses on investigating the cellular and molecular changes that cause myeloid #Leukemia.
September 7, 2025 at 11:52 PM
We are thrilled to announce that Associate Professor @juliamaxson.bsky.social from @ohsuknight.bsky.social, USA, will be joining us at #NDLR2026. Julia's research focuses on investigating the cellular and molecular changes that cause myeloid #Leukemia.
🚨 Call for Abstracts Now Open #NDLR2026 🚨
Only 3 weeks left to submit your abstracts!
🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
🎟️ Earlybird Registration is now open – secure your spot today!
#BloodCancer #CancerResearch #ChildhoodCancer
Only 3 weeks left to submit your abstracts!
🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
🎟️ Earlybird Registration is now open – secure your spot today!
#BloodCancer #CancerResearch #ChildhoodCancer
August 31, 2025 at 11:07 PM
🚨 Call for Abstracts Now Open #NDLR2026 🚨
Only 3 weeks left to submit your abstracts!
🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
🎟️ Earlybird Registration is now open – secure your spot today!
#BloodCancer #CancerResearch #ChildhoodCancer
Only 3 weeks left to submit your abstracts!
🗓 Abstract submission closes 23 September 2025
🩸 Submit now: www.ndlr.org.au
🎟️ Earlybird Registration is now open – secure your spot today!
#BloodCancer #CancerResearch #ChildhoodCancer
🚨 Call for Abstracts Now Open – #NDLR2026 🚨
🗓 Abstract submission closes 23 September 2025
🧬 Submit now: www.ndlr.org.au
Plus, Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer
🗓 Abstract submission closes 23 September 2025
🧬 Submit now: www.ndlr.org.au
Plus, Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer
August 27, 2025 at 10:58 PM
🚨 Call for Abstracts Now Open – #NDLR2026 🚨
🗓 Abstract submission closes 23 September 2025
🧬 Submit now: www.ndlr.org.au
Plus, Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer
🗓 Abstract submission closes 23 September 2025
🧬 Submit now: www.ndlr.org.au
Plus, Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer
We are honoured to welcome Professor John D. Crispino, from
@stjude.bsky.social as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.
@stjude.bsky.social as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.
August 19, 2025 at 11:55 PM
We are honoured to welcome Professor John D. Crispino, from
@stjude.bsky.social as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.
@stjude.bsky.social as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.
We are excited to announce that Dr Elliot Stieglitz will be joining us at NDLR 2026. Hope to see you there. #NDLR2026. #leukaemia #bloodcancer #cancer #research
June 6, 2025 at 5:33 AM
We are excited to announce that Dr Elliot Stieglitz will be joining us at NDLR 2026. Hope to see you there. #NDLR2026. #leukaemia #bloodcancer #cancer #research
We are happy to announce that Dr Jad Othman will be coming to Adelaide for NDLR 2026. #NDLR2026 #bloodcancer.#leukaemia #research #cancer
June 6, 2025 at 5:32 AM
We are happy to announce that Dr Jad Othman will be coming to Adelaide for NDLR 2026. #NDLR2026 #bloodcancer.#leukaemia #research #cancer
We are pleased to announce that A/Prof Jessica Nordlund will be joining us in Adelaide at #NDLR2026. #cancer #leukaemia #research #bloodcancer
June 6, 2025 at 5:31 AM
We are pleased to announce that A/Prof Jessica Nordlund will be joining us in Adelaide at #NDLR2026. #cancer #leukaemia #research #bloodcancer
We are please to announce that Dr Lindsey Montefiori will be joining us as an invited speaker for NDLR 2026. #NDLR2026 #Leukaemia #bloodcancer #research
June 6, 2025 at 5:30 AM
We are please to announce that Dr Lindsey Montefiori will be joining us as an invited speaker for NDLR 2026. #NDLR2026 #Leukaemia #bloodcancer #research
Want to stay up to date with all things surrounding #NDLR2026? Sign up for our mailing list here: eventstudio.eventsair.com/ndlr-2026/
June 6, 2025 at 5:25 AM
Want to stay up to date with all things surrounding #NDLR2026? Sign up for our mailing list here: eventstudio.eventsair.com/ndlr-2026/
